Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00433940 · ClinicalTrials.gov registry record
Immune Suppression Of Infants Treated With Steroids
A clinical trial of Hemangioma, sponsored by Medical College of Wisconsin.
- Completed
- Registry status
- 16
- Enrollment target
- 1
- Study location
NCT00433940: Completed study of Hemangioma, sponsored by Medical College of Wisconsin.
NCT00433940 is a study of Hemangioma that has completed, run by Medical College of Wisconsin. The registered enrollment target is 16 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00433940, a study of Hemangioma, has completed, sponsored by Medical College of Wisconsin.
- COMPLETED
- Registry status
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to clarify the degree of immune suppression in infants requiring therapy and to create guidelines for evaluation and prevention of infection in infants on oral steroids for hemangiomas.
Primary Outcome
Measurement of absolute lymphocyte count and % lymphocyte found during a Complete Blood Count analysis.
Conditions Studied
Interventions
- DRUG Prednisolone
Study Locations (1)
Wisconsin
- Children's Hospital of Wisconsin - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2006-10 |
| Est. Completion | 2010-07 |
What the finished NCT00433940 record still lists
NCT00433940 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 16 participants, a relatively small participant target.
The record links to 1 condition, with Hemangioma appearing as the primary indexed condition, and to 1 intervention - of which Prednisolone is the first listed.
NCT00433940 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT00433940 about?
NCT00433940 is a clinical study titled "Immune Suppression Of Infants Treated With Steroids". The goal of this study is to clarify the degree of immune suppression in infants requiring therapy and to create guidelines for evaluation and prevention of infection in infants on oral steroids for hemangiomas.
What is the current status of trial NCT00433940?
This trial is currently completed. The enrollment target is 16 participants. The study started on 2006-10. Estimated completion is 2010-07.
What conditions does trial NCT00433940 study?
This clinical trial studies the following conditions: Hemangioma.
What interventions are being tested in trial NCT00433940?
The interventions under investigation include: Prednisolone (DRUG).
Who is sponsoring clinical trial NCT00433940?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00433940 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hemangioma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia